Guideline-Based Approaches to Minimize the Progression of COPD: Improving Patient Quality of Life in Long-Term Care

If you cannot view the webcast, click here to download the free Flash Player.

Jointly sponsored by the American Academy of CME, Inc and Princeton CME

Target Audience

This activity is designed for medical directors, consultant pharmacists, and directors of nursing in long-term care.

Learning Objectives

After completing this activity, participants should be able to:

Describe the prevalence and clinical and cost burden of chronic obstructive pulmonary disease (COPD) in the long-term care setting
Outline the frequent characteristics among patients in long-term care facilities that complicate effective COPD management
Summarize the latest evidence-based guidelines for the diagnosis and management of COPD
Apply the latest evidence and guidelines to maximize COPD outcomes and minimize disease progression in long-term care

Credit Eligibility

To be eligible for documentation of credit, individuals must listen to the audio/video component and review the slides for the entire educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: October 10, 2007

Expiration Date: October 10, 2008

Estimated time to complete: 1 hour

There is no fee associated with this activity.

Lecture Components

The audio/video presentation, post-test, and evaluation form are available as a click through via the menu at the top of this page.

CME Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of CME, Inc and Princeton CME. The American Academy of CME, Inc is accredited by the ACCME to provide continuing medical education for physicians.

The American Academy of CME, Inc designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

To contact the American Academy of CME, Inc, please e-mail dbottinick@academycme.org or call 609-921-6622.

This CME activity is recognized by the American Osteopathic Association for a maximum of 1 Category 2 credit.

CNE Accreditation

The American Academy of CME, Inc is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

The American Academy of CME, Inc designates this activity for 1.0 contact hour.

CPE Accreditation

Princeton CME is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education (ACPE Provider #452) and complies with the Criteria for Quality and Interpretive Guidelines. This activity is approved for 1 hour credit (0.1 CEU) of continuing pharmacy education (ACPE #452-999-07-017-H01).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity sponsored or cosponsored by Princeton CME may contact the Assistant Director of Continuing Education in writing. The Assistant Director of Continuing Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Director of Continuing Education may be made for a second level of review.

Grant Support

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc

Presenters

James F. Donohue, MD, FCCP
Professor of Medicine
Chief, Division of Pulmonary and Critical Care Medicine
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, North Carolina

Mark A. Stratton, PharmD, BCPS, CGP, FASHP
Professor of Pharmacy and Langsam Endowed Chair in
Geriatric Pharmacy
Director, Institute for Geriatric Pharmacy
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma

Independent Clinical Reviewers

Imre Noth, MD
Associate Professor of Medicine
University of Chicago
Section of Pulmonary and Critical Care Medicine
Chicago, Illinois

Thomas L. Petty, MD
Professor of Medicine
University of Colorado Health Sciences Center
President, Snowdrift Pulmonary Conference, Inc.
Denver, Colorado

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of the American Academy of CME, Inc and Princeton CME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of the Academy and Princeton CME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Donohue: Advisory board (promotional)—Almirall, Boehringer Ingelheim Pharmaceuticals, GlaxoSmithKline, Novartis; Advisory board (scientific)—Almirall, Boehringer Ingelheim Pharmaceuticals, Dey, GlaxoSmithKline, Novartis, Sepracor; Consultant (scientific)—Almirall, Forest Laboratories, Inc, GlaxoSmithKline, Novartis; Grant/research support—Boehringer Ingelheim Pharmaceuticals, Dey, GlaxoSmithKline, Pfizer, Sepracor (principal investigator; funds paid to University of North Carolina); Speakers bureau—AstraZeneca, Boehringer Ingelheim Pharmaceuticals, GlaxoSmithKline, Pfizer
Dr. Noth: Advisory board (scientific)—GlaxoSmithKline, Novartis; Speakers bureau—GlaxoSmithKline, Pfizer; Contracts for clinical trials— Actelion, Asthmatx, GlaxoSmithKline, Novartis, Roche
Dr. Petty disclosed no relevant financial relationships with any commercial interests.
Dr. Stratton disclosed no relevant financial relationships with any commercial interests.

Planning Committee Debra Bottinick and Natalie Kirkwood, the American Academy of CME, Inc; Randy Robbin and John Savage, Princeton CME; and Mary Johnson and Stacey Ohana, Princeton Media Communications have disclosed they have no relevant financial relationships with any commercial interests.

The American Academy of CME, Inc and Princeton CME require faculty to inform participants whenever off-label/unapproved uses of drugs or devices are discussed in their presentations.

The faculty has disclosed that off-label/unapproved uses of inhaled steroid monotherapy for the treatment of COPD is discussed.